Suppr超能文献

人类布鲁氏菌疫苗的研究进展

Towards a Brucella vaccine for humans.

机构信息

Department of Biomedical Sciences, Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, UK.

出版信息

FEMS Microbiol Rev. 2010 May;34(3):379-94. doi: 10.1111/j.1574-6976.2010.00211.x. Epub 2010 Jan 19.

Abstract

There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines may cause disease and are considered unsuitable for use in humans. However, the causative pathogen, Brucella, is among the most common causes of laboratory-acquired infections and is a Center for Disease Control category B select agent. Thus, human vaccines for brucellosis are required. This review highlights the considerations that are needed in the journey to develop a human vaccine, including animal models, and includes an assessment of the current status of novel vaccine candidates.

摘要

目前,人类尚无布鲁氏菌病的许可疫苗。现有的动物疫苗可能会导致疾病,因此被认为不适合人类使用。然而,病原体布鲁氏菌是实验室获得性感染最常见的原因之一,也是疾病控制与预防中心 B 类选择剂。因此,需要开发人类布鲁氏菌病疫苗。本综述重点介绍了在开发人类疫苗过程中需要考虑的因素,包括动物模型,并评估了新型疫苗候选物的现状。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验